Double maintains 3 strategies that include ITGR - Integer Holdings Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | -25.40% | $11.01B | -96.75% | 2.75% |
FMTO | -23.32% | $45.74M | -99.96% | 0.00% |
CBOE | -17.98% | $22.95B | +20.67% | 1.12% |
VSTA | -9.98% | $326.82M | +11.64% | 0.00% |
LITB | -8.44% | $21.28M | -72.45% | 0.00% |
UUU | -8.14% | $4.93M | +40.20% | 0.00% |
ED | -5.89% | $36.75B | +5.26% | 3.28% |
MO | -5.73% | $97.80B | +26.35% | 6.94% |
K | -5.37% | $28.49B | +32.17% | 2.77% |
STG | -5.13% | $27.05M | -37.35% | 0.00% |
IMMP | -4.87% | $289.16M | -32.19% | 0.00% |
PM | -4.46% | $263.27B | +68.03% | 3.17% |
CPSH | -4.24% | $27.45M | +8.62% | 0.00% |
AWK | -4.12% | $27.37B | +4.54% | 2.22% |
POAI | -3.98% | $9.82M | -34.52% | 0.00% |
VSA | -3.80% | $7.04M | -49.24% | 0.00% |
CHT | -3.75% | $33.79B | +11.52% | 3.35% |
SO | -3.30% | $96.04B | +10.08% | 3.29% |
HSY | -3.15% | $33.16B | -21.37% | 3.44% |
AEP | -3.15% | $54.28B | +9.80% | 3.61% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -51.35% | $140.49M | 0.59% |
VIXY | -50.75% | $109.64M | 0.85% |
BTAL | -43.64% | $361.41M | 1.43% |
IVOL | -32.28% | $353.94M | 1.02% |
FXY | -26.26% | $838.61M | 0.4% |
FTSD | -25.89% | $212.46M | 0.25% |
XONE | -23.13% | $603.24M | 0.03% |
SPTS | -22.62% | $5.76B | 0.03% |
VGSH | -22.61% | $22.38B | 0.03% |
SCHO | -22.05% | $10.87B | 0.03% |
UTWO | -20.77% | $387.71M | 0.15% |
SHYM | -20.61% | $322.93M | 0.35% |
IBTG | -20.30% | $1.88B | 0.07% |
IBTH | -19.21% | $1.53B | 0.07% |
IBTI | -19.12% | $995.39M | 0.07% |
IBTJ | -16.87% | $658.04M | 0.07% |
IEI | -16.35% | $16.09B | 0.15% |
STPZ | -15.39% | $446.46M | 0.2% |
BILS | -15.21% | $3.96B | 0.1356% |
IBTK | -15.01% | $431.59M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TRMB | 59.73% | $17.00B | +24.44% | 0.00% |
AVNT | 58.83% | $3.48B | -16.80% | 2.78% |
ITT | 58.71% | $11.82B | +8.44% | 0.87% |
KN | 58.47% | $1.48B | -2.96% | 0.00% |
APLE | 58.36% | $2.86B | -18.15% | 8.40% |
OSW | 58.32% | $1.98B | +29.62% | 0.62% |
PIPR | 57.51% | $4.71B | +26.93% | 0.96% |
NPO | 57.39% | $3.82B | +21.43% | 0.67% |
AWI | 57.35% | $6.90B | +39.07% | 0.76% |
JXN | 56.77% | $6.09B | +12.55% | 3.41% |
RUSHA | 56.74% | $4.02B | +12.81% | 1.39% |
EQH | 56.64% | $16.06B | +31.34% | 1.82% |
HLNE | 56.62% | $7.37B | +44.47% | 1.15% |
MOG.A | 56.57% | $5.80B | +8.27% | 0.62% |
OC | 56.50% | $12.12B | -17.96% | 1.79% |
GS | 56.49% | $188.98B | +32.59% | 1.90% |
CTS | 56.23% | $1.28B | -17.46% | 0.37% |
BN | 55.92% | $98.39B | +33.78% | 0.55% |
HBAN | 55.82% | $23.45B | +13.62% | 3.87% |
AIT | 55.81% | $8.84B | +17.91% | 0.71% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JMBS | <0.01% | $5.40B | 0.22% |
BKAG | 0.05% | $1.86B | 0% |
TLT | -0.07% | $47.60B | 0.15% |
ZROZ | 0.10% | $1.44B | 0.15% |
GNMA | 0.20% | $355.60M | 0.1% |
HTRB | -0.20% | $1.95B | 0.29% |
BSMR | -0.21% | $245.57M | 0.18% |
ISTB | 0.24% | $4.45B | 0.06% |
SPAB | 0.26% | $8.75B | 0.03% |
JSI | 0.28% | $729.68M | 0.49% |
PULS | -0.31% | $11.17B | 0.15% |
FLCB | -0.32% | $2.52B | 0.15% |
NYF | 0.35% | $875.13M | 0.25% |
BOND | -0.35% | $5.46B | 0.7% |
CANE | 0.43% | $10.71M | 0.29% |
ITM | 0.45% | $1.97B | 0.18% |
GSST | 0.46% | $857.21M | 0.16% |
SMMU | 0.54% | $822.53M | 0.35% |
FMF | 0.59% | $153.73M | 0.95% |
SCHZ | -0.67% | $8.47B | 0.03% |
Yahoo
ECL continues to gain from its robust product portfolio and strong segmental performance.
Yahoo
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.
Yahoo
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging.
Yahoo
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
Yahoo
Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.
Yahoo
PBH experiences steady international growth in the fourth quarter, banking on strong sales of the Hydralyte brand.
Current Value
$119.441 Year Return
Current Value
$119.441 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SLYG | 66.79% | $3.31B | 0.15% |
IJR | 66.77% | $79.01B | 0.06% |
IJT | 66.61% | $6.01B | 0.18% |
XSMO | 66.43% | $1.51B | 0.39% |
SPSM | 66.28% | $11.14B | 0.03% |
NUSC | 66.28% | $1.14B | 0.31% |
FSMD | 66.18% | $1.54B | 0.16% |
JMEE | 66.18% | $1.80B | 0.24% |
VIOO | 66.09% | $2.88B | 0.1% |
DFAS | 65.68% | $9.91B | 0.27% |
VB | 65.62% | $62.13B | 0.05% |
ESML | 65.56% | $1.81B | 0.17% |
XHE | 65.46% | $171.93M | 0.35% |
EZM | 65.41% | $769.65M | 0.38% |
IJS | 65.31% | $6.27B | 0.18% |
FNDA | 65.25% | $8.30B | 0.25% |
XJH | 65.14% | $273.86M | 0.12% |
SCHA | 65.11% | $16.91B | 0.04% |
VIOV | 65.09% | $1.27B | 0.1% |
VBR | 65.06% | $29.30B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XOS | -0.22% | $29.33M | -59.33% | 0.00% |
RLX | -0.30% | $1.77B | -9.30% | 0.49% |
OPTN | -0.31% | $96.41M | -50.80% | 0.00% |
NOVA | 0.50% | $27.46M | -95.24% | 0.00% |
NOC | -0.56% | $67.51B | -0.35% | 1.76% |
PHYS.U | -0.64% | - | - | 0.00% |
DRD | 0.80% | $1.23B | +63.69% | 2.01% |
CME | -0.80% | $98.74B | +28.80% | 3.84% |
BTCT | 0.83% | $25.35M | +93.08% | 0.00% |
JNJ | 0.91% | $360.54B | -3.03% | 3.32% |
EXC | -0.97% | $43.84B | +12.45% | 3.59% |
VZ | -1.16% | $183.32B | +8.02% | 6.21% |
DUK | -1.24% | $90.12B | +12.74% | 3.61% |
MSIF | 1.28% | $715.25M | +28.42% | 7.05% |
BTI | -1.28% | $90.76B | +31.13% | 7.29% |
AMT | -1.35% | $99.10B | +8.59% | 3.09% |
EVRI | 1.63% | $1.22B | +87.10% | 0.00% |
HLF | 1.66% | $720.06M | -36.19% | 0.00% |
NEUE | -1.73% | $62.05M | +13.56% | 0.00% |
PCRX | 1.85% | $1.19B | -18.76% | 0.00% |